Debut Plus

₹48.1

▼ -2.28 -4.53%

17 Jul 2026

BSE Listed

Oxygenta Pharmaceutical Limited (524636)

Volume: 3,548Avg Vol 1W: 6,262Avg Vol 1M: 6,73852W Range:₹43₹113.4
BSE www.oxygentapharma.com
Key Ratios
Checked 10h ago
Market Cap₹186 Cr
Current Price₹48.1
Previous Close₹50.38
High / Low (52w)₹113.4 / ₹43
Volume3,548
Avg Vol (1W)6,262
Avg Vol (1M)6,738
Stock P/E—
Book Value₹-11.54
Dividend Yield0%
ROE41.16%
ROA-14.69%
Revenue (TTM)—
Revenue Growth—
Profit Margin-15.56%
Total Debt—
Shares Outstanding4 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹50.43
200 DMA₹55.52
Day change-4.53%
Price Chart
₹48.1▼ 56.29% · 1Y
₹112₹453.6L
2025-07-17
2026-07-17

20-day avg volume: 7K shares

Pros
  • Healthy return on equity of 41.2%.
  • Company is almost debt-free.
  • Revenue grew 179% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹13 Cr₹14 Cr₹33 Cr₹49 Cr₹15 Cr₹14 Cr₹34 Cr₹50 Cr
EBITDA₹-2 Cr₹-2 Cr₹-5 Cr₹-1 Cr₹-8 Cr₹-5 Cr₹-5 Cr₹1 Cr
Net Profit₹-1 Cr₹-3 Cr₹-4 Cr₹-2 Cr₹-6 Cr₹-5 Cr₹-5 Cr₹-2 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹14 Cr₹21 Cr₹14 Cr₹52 Cr₹61 Cr₹31 Cr₹40 Cr₹111 Cr
EBITDA₹-4 Cr₹-3 Cr₹-9 Cr₹3 Cr₹0 Cr₹-9 Cr₹-12 Cr₹-9 Cr
Net Profit₹-5 Cr₹-3 Cr₹-6 Cr₹3 Cr₹-1 Cr₹-12 Cr₹-3 Cr₹-10 Cr
EPS-4.44-3.19-5.672.87-0.48-8.15-1.04-2.69
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹17 Cr₹21 Cr₹19 Cr₹34 Cr₹31 Cr₹54 Cr₹63 Cr₹83 Cr
Total Liabilities₹49 Cr₹56 Cr₹60 Cr₹72 Cr₹66 Cr₹100 Cr₹83 Cr₹108 Cr
Equity₹-32 Cr₹-35 Cr₹-41 Cr₹-38 Cr₹-35 Cr₹-46 Cr₹-20 Cr₹-25 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-1 Cr₹-2 Cr₹-2 Cr₹-13 Cr₹3 Cr
Investing₹-7 Cr₹-5 Cr₹-10 Cr₹-4 Cr₹-11 Cr
Financing₹9 Cr₹6 Cr₹11 Cr₹17 Cr₹9 Cr
Free Cash Flow₹-1 Cr₹-2 Cr₹-2 Cr₹-13 Cr₹3 Cr
Shareholding
Promoter 56.54% Institutions 0.03% Public 43.44%
Efficiency & Working Capital
ROCE-26%
Interest Coverage-4.7
Dividend Payout—
Debtor Days17 d
Inventory Days69 d
Payable Days99 d
Cash Conversion Cycle-14 d
Working Capital Days86 d
Shareholding Details

As of 2026-03-31

Promoter56.5%
FII0%
DII0%
Institutions0%
Public43.4%
Promoter Pledge0%
No. of Shareholders10,205
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters26.8%29.7%29.7%29.7%33.7%53.3%51.1%51.1%58%58%55.9%56.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public73.2%70.2%70.2%70.2%66.3%46.7%48.9%48.9%42%42%44%43.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders8,9878,9729,05110,1029,97010,15410,10710,03010,09410,17910,21510,205
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Virupaksha Organics LimitedShareholding of Promoter and Promoter Group56.5%2.09 Cr
Sravani Reddy GantlaPublic Shareholding6.8%25,07,660
Subba Reddy BhimavarapuPublic Shareholding4.1%15,32,800
Sunil V. ChawdaPublic Shareholding3%10,97,629
Kumuda KatasaniPublic Shareholding2.3%8,38,291
Aakanksha M ChawdaPublic Shareholding1.5%5,69,616
Manoj S. ChawdaPublic Shareholding1.5%5,69,700
Snigdha VankineniPublic Shareholding1.5%5,43,000
Devarapally Venkateswara ReddyPublic Shareholding1.3%4,85,528
Satyanarayana Reddy BandiPublic Shareholding1.3%4,78,759
B Subba ReddyPublic Shareholding1.3%4,67,400
Chandra Mouliswar Reddy GangavaramShareholding of Promoter and Promoter Group0%12,895
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Chandra Mouliswar Reddy Gangavaram00%2026-03-31
Virupaksha Organics Limited00%2026-03-31
Sunil V. Chawda00%2026-03-31
Snigdha Vankineni00%2026-03-31
Devarapally Venkateswara Reddy00%2026-03-31
Manoj S. Chawda00%2026-03-31
Kumuda Katasani00%2026-03-31
Aakanksha M Chawda00%2026-03-31
Sravani Reddy Gantla00%2026-03-31
Satyanarayana Reddy Bandi00%2026-03-31
B Subba Reddy00%2026-03-31
Subba Reddy Bhimavarapu00%2026-03-31
Board of Directors
NameDesignationYear
Chandra Mouliswar Reddy GangavaramWTD & Executive Director2025
Balasubba Reddy MamillaWTD & Executive Director2025
Vedavathi GangavaramNon Executive Director2025
Veera Reddy AravaIndependent Non Exe. Director2025
Sidda Reddy KanuparthiIndependent Non Exe. Director2025
Sharvari Swapnil ShindeIndependent Non Exe. Director2025
Ms. Kumkum BajajCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
Domestic Sales₹109 Cr99.9%
Export Sales₹0 Cr0.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10383737
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500038240
202500030131
2025000819
Substantial Acquisitions (SAST)

22 disclosure(s)

Market13/02/2026 · 2,33,632
Market13/02/2026 · 2,23,632
Market15/12/2025 · 1,95,885
Off Market18/06/2025 - 20/06/2025 · 20,00,000
Off Market03/06/2025 · 77,52,600
Shr.Purch.Agreement03/06/2025 · 77,52,902
Company Information
Incorporated1990
AuditorA M Reddy & D R Reddy
Investor Email[email protected]; [email protected]; info@sso
🌐 www.oxygentapharma.com ↗

📍 Survey No 252/1 Aroor Village, Sadasivapet Mandal, Medak, Telangana, 502291

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

IEL LimitediStreet Network LimitedGagan Gases Ltd.Parker Agrochem Exports LimitedShukra Pharmaceuticals LimitedAlufluoride Ltd.Archit Organosys Ltd.Sikozy Realtors LimitedIndo AminesNatural CapsulesWelcure Drugs & PharmaceuBharat Immunologicals & BAll “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search